Website Logo

Our Services

Our unique integrated business model, with it’s range of services and capabilities, provides us with an entry point to become the preferred partner to many of the world’s leading pharma and biotech companies.

Our expertise

Bionical Emas are the only Contract Research Organization to combine Clinical DevelopmentClinical Trial Supply (CTS) and Early Access Programs (EAP).

Our unique integrated business model, with it’s range of services and capabilities, benefit many of the world’s leading pharma and biotech companies. This distinctive offering enables us to maximize access and generate evidence at every stage of the drug development pathway.

We have extensive experience across all phases of clinical research, with a rich history in rare disease, oncology/heme-oncology, and infectious diseases.

Case studies

Operational Considerations for Designing and Setting up a Site-less Decentralised Clinical Trial (DCT)

Provided a full-service CRO support for a Phase 2 study to evaluate the safety and efficacy of an intranasal antibody in patients with asymptomatic or mild COVID-19 in the UK.

Case Studies

Global Oncology Phase 3 Rescue Study

Appointed to rescue a full-service, global, randomized Phase 3 oncology trial from a CRO failing to meet a biotechnology client’s expectations regarding enrollment and cost.

Case Studies

Effective Pharmacovigilance & Regulatory EU and Australian Due Diligence, leading to operational and consultative support

A collaboration with US-based SME biotech client to recognize the full potential of their products, offering a significant therapeutic advantage to patients.

Case Studies